Dermatology

Latest News

New Option for Chronic Hand Eczema Gets FDA Green Light: Daily Dose / image credit: ©New Africa/AdobeStock
New Option for Chronic Hand Eczema Gets FDA Green Light: Daily Dose

August 1st 2025

Your daily dose of the clinical news you may have missed.

FDA Approves Delgocitinib, First Treatment for Adults with Moderate to Severe Chronic Hand Eczema / image credit  ©Waldenmarus/Shutterstock.com
FDA Approves Delgocitinib, First Treatment for Adults With Moderate to Severe Chronic Hand Eczema

July 24th 2025

Atopic Dermatitis Flare Frequency May Predict Future Disease Severity, According to New Findings / image credit Courtesy of Bispebjerg Hospital
Atopic Dermatitis Flare Frequency May Predict Future Disease Severity, According to New Findings

July 21st 2025

Lebrikizumab Maintains Skin Clearance Through 3 Years in AD Patients: Daily Dose / image credit: ©New Africa/AdobeStock
Lebrikizumab Maintains Skin Clearance Through 3 Years in AD Patients: Daily Dose

July 21st 2025

Dupilumab Sustains Long-Term Reduction of S. aureus in People with AD: Daily Dose / image credit: ©New Africa/AdobeStock
Dupilumab Sustains Long-Term Reduction of S. aureus in People with AD: Daily Dose

July 16th 2025

Latest CME Events & Activities

More News


Site Logo

Role of Anti–SS-A and Anti–SS-B Tests in Sjögren Diagnosis

December 31st 2006

I enjoyed the article by Kenneth H. Fye, MD, "Rheumatic Disease: How to Use theLab in the Workup" (CONSULTANT, March 2004, page 369). However, I foundthe following statement to be misleading: "Anti-SS-A and anti-SS-B determinationsare necessary to rule out Sjgren syndrome in patients with sicca complaints."If the results of these tests are negative, but Sjgren syndrome was initiallysuspected based on the history, labial biopsy is required. Many persons with thisdisease have negative antibody test results.Unfortunately, it often takes years before Sjgren syndrome is correctly diagnosedin most patients. This is usually because a health care provider rules it outbased on negative results of anti-SS-A and anti-SS-B tests.---- Paula Hochberg, ARNPSarasota, FlaYou are correct that negative results of tests foranti-SS-A and anti-SS-B antibodies do not ruleout Sjgren syndrome. Although the majorityof patients with this syndrome have these antibodies,a significant minority do not. If, in thislatter group of patients, Sjgren syndrome is strongly suspectedon clinical grounds, a minor salivary gland biopsyshould be considered. Biopsy is the most specific andsensitive test for Sjgren syndrome. Although a biopsy isnot required to make the diagnosis in every patient, thereare clearly those with negative tests for anti-SS-A andanti-SS-B in whom a biopsy is necessary to confirm suspectedSjgren syndrome. Thus, my statement shouldhave read instead, "Positive anti-SS-A and anti-SS-B determinationssupport a diagnosis of Sjgren syndrome inpatients with sicca complaints."---- Kenneth H. Fye, MDClinical Professor of MedicineRheumatology DivisionUniversity of California, San Francisco,School of Medicine

© 2025 MJH Life Sciences

All rights reserved.